Concepedia

Ilona Reischl

IR

Statistics

Publications

13

Citations

2.2K

H-Index

12

Active since

1995

Affiliations

National Institutes of Health(Current)

Paul Ehrlich Institut

Austrian Agency for Health and Food Safety

Center for Drug Evaluation and Research

Inserm

Ilona Reischl is an author at National Institutes of Health specializing in life sciences, immunology, and signal transduction.

Publications per year

1995–2023

13

Publications

13

Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

Thomas Lener, Mario Gimona, Ludwig Aigner et al. · Journal of Extracellular Vesicles · 2015 · 1.5K citations · Full text

, , +16

Investigation of Early Events in FcεRI-Mediated Signaling Using a Detailed Mathematical Model

James R. Faeder, William S. Hlavacek, Ilona Reischl et al. · The Journal of Immunology · 2003 · 170 citations · Full text

, , +17

International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19

Verena Börger, Daniel J. Weiss, Johnathon D. Anderson et al. · Cytotherapy · 2020 · 138 citations · Full text

, , +17

Membrane Raft-Dependent Regulation of Phospholipase Cγ-1 Activation in T Lymphocytes

Maria-Concetta Verı́, Karen E. DeBell, Maria‐Cristina Seminario et al. · Molecular and Cellular Biology · 2001 · 63 citations · Full text

, , +17

Surface expression of FcϵRI on Langerhans' cells of clinically uninvolved skin is associated with disease activity in atopic dermatitis, allergic asthma, and rhinitis

Amanda Semper, Kyle Heron, Alexander Woollard et al. · Journal of Allergy and Clinical Immunology · 2003 · 59 citations · Full text

, , +17

1–5 of 13